Are cholinesterase inhibitors now included in the provincial formulary?
No. The results of the evaluation of cholinesterase inhibitors will inform future government policy on coverage of cholinesterase inhibitors. As part of the Alzheimer’s Drug Therapy Initiative, cholinesterase inhibitors are eligible for limited coverage for the period of the evaluation only, currently anticipated at three years.
